First complete genome sequence of ocular isolate carrying blaVim-2 mediated multi-drug-resistant(MDR) Pseudomonas aeruginosa VRFPA04 from India and two draft genome sequence of ocular isolates pseudomonas aeruginosa VRFPA03 and VRFPA05 harboring novel blaDim-1 and blaGes-9 respectively

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 7, Issue 12, 2015, Pages 291-292

  Murugan, N ^a,b   Malathi, J ^a   Umashankar, V ^a   Madhavan, H N ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b SASTRA UNIVERSITY   (India)

Author keywords

Complete genome; Genomics; Multi drug resistant; Pseudomonas aeruginosa

Indexed keywords

CARBAPENEM DERIVATIVE; IMIPENEM; METALLO BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENOME; BACTERIUM ISOLATE; ENDOPHTHALMITIS; HUMAN; KERATITIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NEXT GENERATION SEQUENCING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS AERUGINOSA VRFPA03; PSEUDOMONAS AERUGINOSA VRFPA04; PSEUDOMONAS AERUGINOSA VRFPA05; VITREOUS BODY;

EID: 84949759517     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, Ravindran M, et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Invest Ophthalmol Visual Sci 2012;53:267-72.
2. Otri, AM Fares U, Al‐Aqaba MA, Miri A, Faraj LA, Said DG, et al. Profile of sight-threatening infectious keratitis: a prospective study. Acta Ophthalmol 2013;91:643-51.
3. Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea 2008;27:22-7.
4. OBrien TP, Hazlett LD. Pathogenesis of ocular infection. In: Pepose JS, Holland GN, Wilhelmus KR. Eds; 1999.
5. Harris A, Torres-Viera C, Venkataraman L, DeGirolami P, Samore M, Carmeli Y. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis 1999;28:1128-33.
6. Jiang X, Zhang Z, Li M, Zhou D, Ruan F, Lu Y. Detection of extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006;50:2990-5.
7. Roy PH, Tetu SG, Larouche A, Elbourne L, Tremblay S, Ren Q, et al. Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. PloS One 2010;5:e8842.
8. Murugan N, Malathi J, Therese KL, Madhavan HN. Antimicrobial susceptibility and prevalence of extended spectrum beta-lactamase (ESBL) and metallo betalactamases (MBLs) and its co-existence among pseudomonas aeruginosa recovered from ocular infections. Int J Pharm Pharm Sci 2015;7:5.
9. Malathi J, Murugan N, Umashankar V, Bagyalakshmi R, Madhavan HN. Draft genome sequence of multidrug-resistant Pseudomonas aeruginosa strain VRFPA02, isolated from a septicemic patient in India. Genome Announcements 2013;1:e00425-13.
10. Murugan N, Malathi J, Umashankar V, Madhavan HN. Comparative genomic analysis of multidrug-resistant pseudomonas aeruginosa clinical isolates VRFPA06 and VRFPA08 with VRFPA07. Genome Announcements 2014;2:e00140-14.
11. Murugan N, Malathi J, Umashankar V, Madhavan HN. Draft genome sequence of bla Veb-1, bla oxa-10 producing multi-drug resistant (MDR) Pseudomonas aeruginosa strain VRFPA09 recovered from blood stream infection.Braz J Microbiol 2015;46:639-40.
12. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, et al. The RAST server: rapid annotations using subsystems technology. BMC Genomics 2008;9:75.
13. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 2012;67:2640-4.